Online posts are self-reported and cannot always be independently verified
Endocrine 59 (2), 383394
Skip to content Page load link Go to Top total med solutions, botox, dysport, hormone replacement therapy, total med, treatment, units, semaglutide, tirzeptide, allen, plano, hurst, flower mound, fort worth, dallas, southlake, medical weight loss, weight loss program Frequently Asked Questions How can I initiate an appointment for weight loss treatments
Seven in ten reported that they used the medications to treat a chronic condition such as heart disease or diabetes rather than to treat obesity
Additionally, per publicly available FDA and manufacturer announcements, orforglipron (Eli Lilly's Foundayo, a non-peptide oral GLP-1 receptor agonist) received FDA approval on April 1, 2026 for chronic weight management